Roche, Sanofi arthritis drugs reduce death rates among sickest COVID-19 patients – Reuters India

Roche, Sanofi arthritis drugs reduce death rates among sickest COVID-19 patients – Reuters India

Treating critically ill COVID-19 patients with Roche’s Actemra or Sanofi’s Kevzara arthritis drugs significantly improves survival rates and reduces the amount of time patients need intensive care, study results showed on Thursday.

Read More…

You May Also Like